VivoSeq
Other

Antibiotic

0

Pipeline Programs

9

Active Trials

5

Companies Involved

Antibiotic is an early-stage landscape with 0 programs across 5 companies. The most active players are Pfizer, Sanofi, GSK.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

69

clinical trials

Completed43 · 62%
Unknown status12 · 17%
Recruiting6 · 9%
Terminated3 · 4%
Not yet recruiting3 · 4%
Suspended1 · 1%
Other1 · 1%

Trial Activity

69 trials

Precision Antibiotic Dosing for Appendectomy
Recruiting·UUniversity of Michigan·Phase 1·NCT06860802·46 enrolled
The MANTRA Trial (MANdibular TRauma and Antibiotic Use)
Recruiting··Phase 3·NCT05964140·2,841 enrolled
Prophylactic Antibiotic in Subtalar Fusion Surgery
Not yet recruiting··Phase 2/3·NCT06527989·102 enrolled
Antibiotic "Dysbiosis" in Preterm Infants
Completed·UUniversity of Florida·Phase 2·NCT02784821·98 enrolled
Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)